In line with the hypothesis that G-CSF/GM-CSF treatment is associated with the development of lung damage, Verhoef et al. reported a case of a patient who developed ARDS during treatment with rhGM-CSF for severe transfusion-dependent refractory anemia with excess of blasts [27]. This evidence concerns the gene CSF3 and anemia (phenotype).